Kubernetes: A Gateway Drug for Vendor Lock-in
Please log in to watch this conference skillscast.
Many organisations believe to be betting on interoperability by choosing Kubernetes rather than, what they believe to be, a proprietary platform. However, this could be a trap that can easily lead to vendor lock-in.
Many organisations believe to be betting on interoperability by choosing Kubernetes rather than, what they believe to be, a proprietary platform. However, this could be a trap that can easily lead to vendor lock-in. We need to learn from history to avoid repeating the same mistake again.
YOU MAY ALSO LIKE:
- Docker Fundamentals with Matt Saunders (Online Course on 22nd - 25th February 2021)
- Advanced Kubernetes Concepts with Jérôme Petazzoni (Online Course on 22nd - 25th March 2021)
- Introducing AWS Immersion Days (Online Meetup on 11th February 2021)
- Event-Driven Microservices: The Sense, Nonsense and a Way Forward (SkillsCast recorded in December 2020)
- Lightning Talk: E Pluribus Unum – Adventures in Polycloud Delivery (SkillsCast recorded in December 2020)
Thank you to our sponsors and partners
Platinum
Gold
Kubernetes: A Gateway Drug for Vendor Lock-in
Ernesto Garbarino
Ernesto Garbarino is Enterprise Architect, Cloud Evangelist and Account CTO at Mphasis, a Blackstone company. Mr. Garbarino holds an MSc in Software Engineering from University of Oxford with Distinction as well as two diplomas in Computing from the same institution. He is also the author of “Beginning Kubernetes on the Google Cloud Platform”, published by Apress.